Replies to post #21476 on RespireRx Pharmaceuticals Inc (fka RSPI)

[enemem]

I think that even with competing offers, cor is going to end up with a less lucrative deal than either cor management or poseters on this board have foreseen. Less funding sources skews partnering in favor of BPs.